Posts by Sandra Ansanay-Alex
Vesalius Innovation Award
Apply before 3 August 2025 for the Vesalius Innovation Award For the sixth consecutive year, Karger Publishers is seeking top-of-the-line applicants for its Vesalius Innovation Award. This year, the award welcomes early-stage startups that are reimagining how scientific knowledge is communicated, evaluated, and applied. All fields – especially those with relevance to Health Sciences,…
Read MoreSwiss Health Valley Startups Shine at Major Pitching Events
The Swiss Health Valley continues to be a powerhouse of innovation, as multiple startups made their mark at major pitching events across Europe. These groundbreaking companies are not only transforming health and wellness but also bringing international recognition to the region. At Start Contest 2024-2025, PMAX Labs emerged as the grand prize winner…
Read MoreInnobooster Gebert Rüf Stiftung
Apply before 1 September 2025 for the Gebert Rüf Stiftung Innobooster and get up to CHF 150,000 Gebert Rüf Stiftungsupports university-based, high-potential businesses from the Venture Kick program with the aim of substantially accelerating their market entry. The funding line is calling for top talents with convincing proposals of how a research &…
Read MoreTEDD Visit: Tissue Engineering & Organoid (TEO) Technology Centre – UNIGE
Organised by Biotechnet, this TEDD visit at the Tissue Engineering & Organoid (TEO) Technology Centre at University of Geneva is organised on 19 June 2025 In an effort to fully leverage the potential of tissue engineering and organoid-based technologies while promoting innovative strategies, the Faculty of Medicine of the University of Geneva established in…
Read MoreIdiap Create Challenge
The 14th edition of the Idiap Create Challenge (ICC), a 9-day hackathon dedicated to artificial intelligence, is taking place from 21 to 29 August 2025 in Martigny. The ICC, organised in partnership with The Ark Foundation, offers a unique environment where participants benefit from Idiap’s recognised expertise in artificial intelligence. On the programme:…
Read MoreDigital Health Projectathon
The Digital Health Projectaton, organised by eHealth Suisse is taking place from 15 to 19 September in Bern The Digital Health Projectathon is an interoperability and conformity test marathon. For five days, participants can test their own products live on site for interoperability and, if necessary, adapt them to the findings during the event.…
Read MoreSyrhatech Completes A CHF 4.5 Million Financing Round
Syrhatech, a French-Swiss CDMO innovating in the development and manufacture of injectable medical devices based in particular on hyaluronic acid, announces the closing of an investment of CHF 4.5 million, completed with strategic investors. Funding for innovation and industrial capacity This investment will enable Syrhatech to strengthen its R&D team at its site in Geneva, and to deploy a…
Read MorePANORAMAI
Panoramai is taking place from 3 to 5 June 2025 at Campus Unlimitrust in Renens Within the Gen AI ecosystem, discover real-life use cases and AI-powered digital transformation stories with entrepreneurs and business experts. The event also aims to enrich the horizons and potential applications of AI by exploring creative perspectives on uses and…
Read MoreHLTH Europe
HLTH Europe is taking from 16 to 19 June 2025 in Amsterdam The leading innovation event is dedicated to shaping the future of healthcare. Taking place in Amsterdam, HLTL Europe is bringig together 5000+ global healthcare leaders, innovators, and policymakers to explore the latest advancements in medical technology, patient care, and healthcare investment. +5000…
Read MoreNewBiologix Licences Xcell-Eng-HEK293 Cell Line to Recipharm
NewBiologix, a Biopôle-based (Vaud)Swiss biotech innovator, has granted a non-exclusive licence to Recipharm Advanced Bio. The agreement gives Recipharm access to NewBiologix’s Xcell-Eng-HEK293 cell lines, enabling the efficient production of recombinant Adeno-Associated Viruses (rAAVs) for cell and gene therapies. The licensed cell lines offer high-yield, GMP-ready viral production, accelerating the path to clinical trials.…
Read More